Part 3: Treatment of malaria and resulting resistances


If an infection with malaria is existing (testing see previous post), it has to be treated, because untreated it can lead to death. The treatment depends on the type of malaria and the intensity of the disease. In Tanzania, it is differentiated between malaria tropica, malaria tertiana and malaria quartana.

In the case of uncomplicated disease, the therapy is carried out with medication. In case of a serious course of the disease or an already advanced disease, it has to be treated in a hospital.


The fight against malaria is made more difficult by drug-resistant parasite strains. Due to genetic mutations of the mosquitoes, some drugs are no longer effective. The resistance evolve because often only rapid tests are made, which only show whether there is an infection or not, but not with which type of malaria one is infected. In many cases drugs are then given which are non adjusted and ineffective for the specific form of malaria. This makes the mosquitoes resistant to the drugs. In the worst case, the patient's malaria also worsens because he or she has received an ineffective drug.



The clinic in Kabanga has a microscope, which is necessary to identify the type of malaria. If a malaria screening takes place in the clinic, the patient is also given the appropriate drug for treatment.


For about half a year now, there has been a recommendation from the WHO for approval of a vaccine against malaria for young children.


#malaria #tanzania #kabanga #endmalaria #basichealthcare #acesstohealthcareforall



sources:

https://gesund.bund.de/malaria#diagnostik (zuletzt aufgerufen: 14.04.22)

https://apps.who.int/iris/rest/bitstreams/1398397/retrieve (zuletzt aufgerufen: 14.04.22)

https://tropeninstitut.de/aktuelle-krankheitsmeldungen/04.01.2021-studie-malaria-resistenz (zuletzt aufgerufen: 14.04.22)

https://www1.wdr.de/nachrichten/malaria-impfstoff-kinder-100.html (zuletzt aufgerufen: 14.04.22)

https://www.swr.de/wissen/wie-gut-ist-der-malaria-impfstoff-100.html (zuletzt aufgerufen: 14.04.22)